(Date:11/30/2009)...0 Novavax, Inc. (Nasdaq:...ed today that the company will be presenting at th...ber 2, 2009 at 12:30 pm local time at The New York...ew of the company,s business strategy, research an... link to the live audio only presentation can be a...
(Date:11/30/2009)...wire/ -- Dr. Jessica Torrente, Assistant Professor...cal Center in Washington, D.C., demonstrated the i...g (BSGI) in clinical practice as an adjunct imagin...y at the annual meeting of the Radiological Societ...he exhibit was to demonstrate how BSGI is used in ...
(Date:11/30/2009)... BioMarin Pharmaceutical ...d and Drug Administration (FDA) has granted orphan...), amifampridine phosphate, for the rare autoimmun.... 3,4-DAP has previously received orphan drug des...ommittee for Medicinal Products for Human Use of t...
(Date:11/30/2009)..., Nov. 30 Exiqon A/S (NASDAQ OMX C... Medical School ICCB-Longwood Screening Facility (...g Center of Excellence. ICCB-L supports investiga...pitals and institutions, for high-throughput scree...icroRNAs are a novel class of small, non-coding RN...
Breaking Biology Technology:NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3...7 The market for congestive heart,failure (CHF) d...7, and is,expected to reach $30 billion by 2017, a...Congestive Heart Failure: Major World Markets, Vol...driven by three factors: an,increased incidence of...n,search of targeted therapies which is creating o...
...ril 17 Spherix Incorporated,(Nasdaq: SPEX ) anno...perations. Mr. Brown will be monitoring and overse...rial regarding the use of Naturlose(R) as a,treatm...as allowed Spherix,to terminate its agreement with...r full control of the clinical trial and its pivot...
...7 SPO Medical Inc. (OTC:,SPOM), a leading develop...r,use in portable monitoring devices, today announ...Capital Ventures (ACV), a leading provider of,comp... cap community, as an,investor relations consultan...ve Officer of SPO Medical,commented, "As we contin...
Other Biology Technology:Genomics Likely to Replace Traditional Drug Therapies in Treating CHF 2Spherix Hires Key Employees 2SPO Medical Retains American Capital Ventures for Investor Relations Services 2SPO Medical Retains American Capital Ventures for Investor Relations Services 3Iscove's Modified Dulbecco's Medium (IMDM) from Sigma-Aldrich
Dulbecco's Modified Eagle's Medium - high glucose (DME) from Sigma-Aldrich
...r routine procedures. Hollandes contains formaldeh...l decalcify small bone specimens. Tissue that is f...ith most stains, and the cupric acetate in the sol...nophil and endocrine cell granules so that less ly...
...tograph/Mass Spectrometer, utilizing many of the h...igh throughput and excellent productivity, providi...io. Like the GCMS-QP2010 Plus, the GCMS-QP2010s fe...um separation, 20 temperature ramps, and both scan...
Biology Products: